In the mammary 4T1 tumor model, overexpression of IL-1β (in the tumor or the host) or the invalidation of IL-1RA led to an accumulation of Ly6C negative MDSCs, that is, polymorphonuclear (PMN)-MDSCs, whereas blocking IL-1β decreases the number of MDSCs. This evidence concerns the gene IL1B and neoplasm.